During the past decade, Endocrinology & Diabetes Consultants conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Endocrinology & Diabetes Consultants" are "Obesity" (4 trials), "Overweight" (2 trials), "Diabetes Mellitus, Non-Insulin-Dependent" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Obesity in Diabetes" (1 trials). Many other conditions were trialed in "Endocrinology & Diabetes Consultants" in a lesser frequency.

Most popular intervention types in "Endocrinology & Diabetes Consultants" are "Drug" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ancillary therapy" (2 trials), "Placebo" (2 trials), "Rimonabant (SR141716)" (2 trials), "Naltrexone SR 32 mg/bupropion SR 360 mg/ day" (1 trials) and "Naltrexone SR 32 mg/bupropion SR 360 mg/day" (1 trials). Other intervention names were less common.

The vast majority of trials in "Endocrinology & Diabetes Consultants" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Endocrinology & Diabetes Consultants". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Endocrinology & Diabetes Consultants, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Endocrinology & Diabetes Consultants, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".